|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Subscription Information
Editorial Office
Publish with CMH
Instructions for Authors
Peer Review and Publishing
Checklist
E-Submission
Copyright Transfer Form
Journal Archive
Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Clin Mol Hepatol
Search
Author Index
Clinical and Molecular Hepatology
Search
> Browse Articles > Search
KASL clinical practice guidelines for management of
chronic hepatitis B
Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.
2019;25(2):93-159. Published online June 12, 2019
DOI:
https://doi.org/10.3350/cmh.2019.1002
Cited By 7
Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying
chronic hepatitis B
Hyeji Kim, Jung Hyun Kwon, Yong Hee Kim, Soon Woo Nam, Jong Yul Lee, Jeong Won Jang
Clin Mol Hepatol.
2018;24(4):430-435. Published online November 27, 2017
DOI:
https://doi.org/10.3350/cmh.2017.0016
Characterization and evaluation of liver fibrosis grade in patients with
chronic hepatitis B
virus infection and normal transaminases
San Juan López Cristina, Casado Martín Marta, González Sánchez Mercedes, Porcel Martín Almudena, Hernández Martínez Álvaro, Vega Sáenz Jose Luis, Parrón Carreño Tesifón
Clin Mol Hepatol.
2018;24(4):384-391. Published online July 4, 2018
DOI:
https://doi.org/10.3350/cmh.2018.0004
Cited By 2
Management of
chronic hepatitis B
patients in immunetolerant phase: what latest guidelines recommend
Grace Lai-Hung Wong
Clin Mol Hepatol.
2018;24(2):108-113. Published online January 22, 2018
DOI:
https://doi.org/10.3350/cmh.2017.0068
Cited By 8
Is it possible to predict the development of an entecavir resistance mutation in patients with
chronic hepatitis B
in clinical practice?
Joon Yeul Nam, Jeong-Hoon Lee
Clin Mol Hepatol.
2017;23(4):311-313. Published online December 4, 2017
DOI:
https://doi.org/10.3350/cmh.2017.0069
Efficacy of tenofovir-based rescue therapy for
chronic hepatitis B
patients with resistance to lamivudine and entecavir
Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin
Clin Mol Hepatol.
2017;23(3):230-238. Published online June 30, 2017
DOI:
https://doi.org/10.3350/cmh.2017.0003
Cited By 4
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Yun Bin Lee, Jeong-Hoon Lee
Clin Mol Hepatol.
2017;23(3):219-221. Published online September 19, 2017
DOI:
https://doi.org/10.3350/cmh.2017.0045
Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for
chronic hepatitis B
Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik
Clin Mol Hepatol.
2017;23(2):170-178. Published online May 16, 2017
DOI:
https://doi.org/10.3350/cmh.2016.0086
Cited By 6
Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with
chronic hepatitis B
Hee Yeon Seo, Han Ah Lee, Soon Young Ko, Joon Ho Wang, Jeong Han Kim, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.
2017;23(2):154-159. Published online May 8, 2017
DOI:
https://doi.org/10.3350/cmh.2016.0067
Cited By 2
Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi
Clin Mol Hepatol.
2016;22(4):458-465. Published online December 25, 2016
DOI:
https://doi.org/10.3350/cmh.2016.0054
Cited By 3
Efficacy of switching from adefovir to tenofovir in
chronic hepatitis B
patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn
Clin Mol Hepatol.
2016;22(4):443-449. Published online November 25, 2016
DOI:
https://doi.org/10.3350/cmh.2016.0037
Cited By 5
Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
Byung-Cheol Song
Clin Mol Hepatol.
2016;22(4):439-442. Published online December 25, 2016
DOI:
https://doi.org/10.3350/cmh.2016.0108
New perspectives of biomarkers for the management of
chronic hepatitis B
Chih-Lin Lin, Jia-Horng Kao
Clin Mol Hepatol.
2016;22(4):423-431. Published online December 25, 2016
DOI:
https://doi.org/10.3350/cmh.2016.0069
Cited By 26
Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi
Clin Mol Hepatol.
2016;22(3):350-358. Published online September 25, 2016
DOI:
https://doi.org/10.3350/cmh.2016.0019
Obesity and hepatocellular carcinoma in patients receiving entecavir for
chronic hepatitis B
Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park
Clin Mol Hepatol.
2016;22(3):339-349. Published online September 25, 2016
DOI:
https://doi.org/10.3350/cmh.2016.0021
Cited By 4
Does obesity increase the risk of hepatocellular carcinoma in
chronic hepatitis B
patients?
Byoung Kuk Jang
Clin Mol Hepatol.
2016;22(3):336-338. Published online September 25, 2016
DOI:
https://doi.org/10.3350/cmh.2016.0104
Tenofovir-associated nephrotoxicity in patients with
chronic hepatitis B
: two cases
Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol.
2016;22(2):286-291. Published online June 25, 2016
DOI:
https://doi.org/10.3350/cmh.2015.0066
Cited By 5
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clin Mol Hepatol.
2016;22(2):241-249. Published online June 15, 2016
DOI:
https://doi.org/10.3350/cmh.2015.0053
Cited By 3
Is the tenofovir based therapy almighty for previous treatment failure in
chronic hepatitis B
?
Hyung Joon Yim
Clin Mol Hepatol.
2016;22(2):238-240. Published online June 25, 2016
DOI:
https://doi.org/10.3350/cmh.2016.0103
Cited By 1
Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant
chronic hepatitis B
Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park
Clin Mol Hepatol.
2016;22(1):152-159. Published online March 28, 2016
DOI:
https://doi.org/10.3350/cmh.2016.22.1.152
KASL clinical practice guidelines: management of
chronic hepatitis B
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.
2016;22(1):18-75. Published online March 28, 2016
DOI:
https://doi.org/10.3350/cmh.2016.22.1.18
Cited By 83
Erectile dysfunction in patients with liver disease related to
chronic hepatitis B
Min Kim, Seul Young Kim, Woo Sun Rou, Se Woong Hwang, Byung Seok Lee
Clin Mol Hepatol.
2015;21(4):352-357. Published online December 24, 2015
DOI:
https://doi.org/10.3350/cmh.2015.21.4.352
Cited By 8
Entecavir plus tenofovir versus entecavir plus adefovir in
chronic hepatitis B
patients with a suboptimal response to lamivudine and adefovir combination therapy
Jung Gil Park, Soo Young Park
Clin Mol Hepatol.
2015;21(3):242-248. Published online September 30, 2015
DOI:
https://doi.org/10.3350/cmh.2015.21.3.242
Cited By 1
Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure
Jung Min Ha, Won Sohn, Ju Yeon Cho, Jeung Hui Pyo, Kyu Choi, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Chul Koh, Seung Woon Paik, Byung Chul Yoo, Yong-Han Paik
Clin Mol Hepatol.
2015;21(3):232-241. Published online September 30, 2015
DOI:
https://doi.org/10.3350/cmh.2015.21.3.232
Cited By 2
Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in
chronic hepatitis B
patients
Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim
Clin Mol Hepatol.
2015;21(2):131-140. Published online June 26, 2015
DOI:
https://doi.org/10.3350/cmh.2015.21.2.131
Cited By 2
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced
chronic hepatitis B
patients
Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa
Clin Mol Hepatol.
2015;21(1):41-48. Published online March 25, 2015
DOI:
https://doi.org/10.3350/cmh.2015.21.1.41
Cited By 8
The factors associated with longitudinal changes in liver stiffness in patients with
chronic hepatitis B
In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
Clin Mol Hepatol.
2015;21(1):32-40. Published online March 25, 2015
DOI:
https://doi.org/10.3350/cmh.2015.21.1.32
Cited By 10
Efficacy of prolonged entecavir monotherapy in treatment-naïve
chronic hepatitis B
patients exhibiting a partial virologic response to entecavir
Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim
Clin Mol Hepatol.
2015;21(1):24-31. Published online March 25, 2015
DOI:
https://doi.org/10.3350/cmh.2015.21.1.24
Cited By 11
Personalized treatment of hepatitis B
Anna S. Lok
Clin Mol Hepatol.
2015;21(1):1-6. Published online March 25, 2015
DOI:
https://doi.org/10.3350/cmh.2015.21.1.1
Cited By 13
Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive
chronic hepatitis B
in endemic areas of HBV genotype C?
[corrected-article]
Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong
Clin Mol Hepatol.
2014;20(4):355-360. Published online December 24, 2014
DOI:
https://doi.org/10.3350/cmh.2014.20.4.355
Cited By 4
1
|
2
|
3
|
> Browse Articles > Search
